{
  "id": 9460597,
  "title": "Atomo FY26 slides: 41% revenue growth, new CEO named",
  "url": "https://urgent.news/2026/09/24/atomo-fy26-slides-41-revenue-growth-new-ceo-named",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-24T01:38:35.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/atomo-fy26-slides-41-revenue-growth-new-ceo-named-93CH-4914336"
  },
  "original_language": "en",
  "account": "Atomo Diagnostics reported a 41% increase in revenue for fiscal 2026, reaching A$5.3 million, while its underlying EBITDA loss narrowed by 39% to A$2.06 million. The company's shares closed near A$0.02, reflecting cautious market sentiment despite the improvements. Dr. Cheri Walker was appointed as Interim CEO, replacing founder John Kelly after 15 years of leadership. The company is transitioning to sustainable revenue growth with a growing product pipeline, focusing on point-of-care diagnostic products for global markets.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Atomo FY26 slides: revenue surges 41% amid CEO transition",
        "url": "https://urgent.news/2026/09/24/atomo-fy26-slides-revenue-surges-41-amid-ceo-transition",
        "published": "2026-09-24T01:41:04.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}